| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000005507 |
| Receipt No. | R000006117 |
| Official scientific title of the study | Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting. |
| Date of disclosure of the study information | 2011/04/26 |
| Last modified on | 2016/12/18 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting. | |
| Title of the study (Brief title) | Evaluation on an introduction method of fentanyl patch by using short-acting opioid for cancer pain management in the outpatient setting.(Miyagi-HBPCOG 008) | |
| Region |
|
|
| Condition | |||||
| Condition | Cancer Pain | ||||
| Classification by specialty |
|
||||
| Classification by malignancy | Malignancy | ||||
| Genomic information | NO | ||||
| Objectives | |
| Narrative objectives1 | Evaluation on efficacy and safety of the introduction method by using short-acting opioid for cancer pain patients in the outpatient setting. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Pain Relief Rate |
| Key secondary outcomes | Adverse Effect
Quality of life Patient Satisfaction Compliance |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | introduction method of fentanyl patch by using short-acting opioid for cancer pain management | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Cancer pain patients with various
malignant tumors. Patient with 20 years of age or more at the date of consent agreement. Patients considered as appropriate for the treatment of opioid by investigators. |
|||
| Key exclusion criteria | Patients with hypersensitivity to opioid
Patients with medical history of opiod addiction Patients considered necessary for titration inpatient setting Patients with respiratory dysfunctions such as chronic lung disease Patients with asthma Patients with serious heart dysfunction Patients with serious hepatic or renal dysfunction Patients with intracranial hypertension and disturbed consciousness Patients with skin disease such as eczema and atopy at the attached site Patients with 40 degree or more fever Homeostatically Pregnant patients and patients who may possibly be pregnant. Patients treated with opioid antagonists such as pentazocine and buprenorphine within 2 days prior to fentanyl patch attachment. Patients under the age of 20 Patients considered as inappropriate for study by investigator |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Michiaki Unno |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Division of Hepato-Biliary Pancreatic Surgery Department of Surgery |
| Address | 1-1 Seiryou-machi, Aoba-ku, Sendai, Miyagi, 980-8574 Japan |
| TEL | |
| Public contact | |
| Name of contact person | Kei Nakagawa |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Division of Integrated Surgery and Oncology |
| Address | |
| TEL | 022-717-7205 |
| Homepage URL | |
| kein_h11@surg1.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Tohoku University Graduate School of Medicine Division of Integrated Surgery and Oncology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | Miyagi HBPCOG |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006117 |